HIV Lipodystrophy
Information
- Disease name
- HIV Lipodystrophy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00362440 | Completed | Phase 2 | Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome | August 2006 | June 2011 |
| NCT00627380 | Completed | Phase 4 | Yoga for the Management of HIV-Metabolic Syndromes | November 2005 | June 2009 |
| NCT00656851 | Completed | N/A | Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome | September 2005 | August 2010 |
| NCT00795210 | Completed | N/A | Effects of Short-term Growth Hormone in HIV-infected Patients | February 2009 | November 2012 |
| NCT01263717 | Completed | N/A | Effects of Growth Hormone Releasing Hormone in HIV | December 2010 | February 2014 |
| NCT04904406 | Completed | Phase 4 | Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals | October 22, 2020 | December 1, 2023 |
| NCT05383456 | Completed | The Visceral Adiposity Measurement and Observation Study | April 18, 2022 | October 30, 2023 | |
| NCT01511016 | Completed | N/A | Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome | February 2003 | October 2011 |
| NCT03039491 | Completed | Early Phase 1 | Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults | September 1, 2015 | March 30, 2020 |
| NCT01329744 | Terminated | Phase 1 | Effects of IGF-I in HIV Metabolic Disease | June 2011 | June 2013 |
| NCT04903847 | Unknown status | Phase 4 | Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil | February 2, 2021 | February 2, 2023 |